MAP Insights

A more in-depth look at news, policies and developments. Insights from both our in-house team of consultants in policy, public affairs, health economics and market access, as well as a roster of external experts with a wealth of knowledge and expertise.


The NHS Commercial Framework and the options it provides
Published 11th March 2021

The NHS Commercial Framework for New Medicines has been published. It aims to support patient access to affordable and transformative medicines. MAP provides insights into the effect it will have on the industry going forward.

Read more
Analysis of the new NHS White Paper – Part 1

Analysis of the new NHS White Paper
Published 19th February 2021

The New NHS White Paper on reforming the NHS, Integration and Innovation: working together to improve health and social care for all, which was foreshadowed in MAP’s blog on 9 February, was published on 11 February.

Read more
Analysis of the new NHS White Paper – Part 2

Terms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021. MAP BioPharma Limited. All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number GB 292 8576 52